To determine if differences in Braak tangle stage contributed to the difference in cathepsin activity between EOAD and AD-DS, we repeated our analysis comparing AD-DS (Braak VI, 6 cases) with EOAD (Braak VI, 9 cases) and healthy ageing (Braak 0-II, 10 cases). This evidence concerns the gene CTSS and Dravet syndrome.